Category Archives: Blog

Blog

Respiratory RT-PCR Panels: Viral and Bacterial Targets

Posted on by JantDX
Respiratory RT-PCR Panels
28
Feb

Respiratory infections can involve multiple viral and bacterial pathogens with overlapping clinical presentations. Real-time PCR (RT-PCR) technology enables laboratories to detect selected nucleic acid targets through amplification and fluorescence-based detection. Multiplex respiratory RT-PCR panels combine multiple predefined targets into a single testing workflow, helping research laboratories evaluate respiratory pathogen targets while reducing the need for […]

Continue reading →
Blog

COVID-19, Flu, and RSV Continue to Impact Public Health

Posted on by JantDX
COVID-19 Flu and RSV
10
Feb

Respiratory viruses COVID-19, Influenza, and RSV share similar symptoms, making accurate testing essential. With current positivity rates for Influenza (31.6%), COVID-19 (4.8%), and RSV (6.8%) (CDC), broad testing helps distinguish between these infections and guide appropriate treatment. Symptoms and Risk Factors While these viruses share overlapping symptoms such as fever, cough, and shortness of breath, […]

Continue reading →
Blog

How Genetic Testing Can Help Predict Opioid Use Disorder Risk

Posted on by JantDX
Opioid Use Disorder Risk
13
Nov

AvertD is an FDA-approved genetic test that uses advanced scientific techniques to identify individuals at higher genetic risk for developing opioid use disorder (OUD)1. By analyzing DNA, the test detects 15 specific genetic polymorphisms that may be linked to an increased susceptibility to OUD, including variations in genes related to serotonin, dopamine, and opioid receptors […]

Continue reading →
Blog

LCMS Testing of Xylazine

Posted on by JantDX
LCMS Testing of Xylazine
24
Jul

Xylazine, an approved animal tranquilizer in the U.S., acts as a sedative and analgesic for veterinary use [1]. It is an α-2 adrenoreceptor agonist, detected in the unregulated drug supply throughout the eastern United States and Canada [2]. It has been detected in 91% of fentanyl/ heroin samples in Philadelphia and showed its presence in national […]

Continue reading →
Blog

Fentanyl Immunoassay is a Vital Tool in the Battle Against Opioid Crisis

Posted on by JantDX
Fentanyl Immunoassay
09
Jan

Fentanyl is a synthetic opioid that is 50 to 100 times more potent than morphine. It is used to treat patients with severe pain after surgery, especially those who are physically tolerant to other opioids [1]. However, it is often abused illegally and mixed with other drugs, which can result in dangerous respiratory depression. The […]

Continue reading →
Blog

BNP vs NT-proBNP

Posted on by JantDX
BNP vs NT-proBNP
15
Sep

Heart failure (HF) is a complex clinical syndrome affecting 6.2 million people in the United States [1]. The diagnosis of heart failure is challenging as patients usually present non-specific symptoms, which are often shared by other diseases. Both B-type natriuretic peptide (BNP) and the N-terminal pro BNP (NT-proBNP) are widely used as biomarkers to diagnose […]

Continue reading →
Blog

Fentanyl Overdose Increase and the Opiate Epidemic in the USA

Posted on by JantDX
Fentanyl Overdose Increase
12
Jul

What is Fentanyl? Fentanyl is a synthetic opioid that was first developed in 1959 and introduced in the 1960s as an intravenous anesthetic. Fentanyl was also used for pain management as a transdermal patch in cancer patients. It is 50-100 times stronger than morphine. As an illicit drug, fentanyl is added to heroin to increase potency. […]

Continue reading →